Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 1,001–1,100 of 2,013
Tumorigenic Aspects of MSC Senescence—Implication in Cancer Development and Therapy
Mojsilović, S. B., Jauković, A., Кукољ, Т., Obradović, H., Djordjević, I. O., Petrović, A., & Bugarski, D. S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111133 · Cited by 27
“well as a mechanism for promotion of tissue repair [5].”
BackgroundRusso, M., Spagnuolo, C., Moccia, S., Tedesco, I., Lauria, F., & Russo, G. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010301 · Cited by 21
Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism
Tessier, S., Martín-Martín, N., de Thé, H., Carracedo, A., & Lallemand-Breitenbach, V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6898 · Cited by 28
“However, many factors of this senescence-associated secretory phenotype also have protumorigenic properties (96).”
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“Hence, SASP secretion can have adverse effects on the physiology of an aged organism via chronic inflammation and multiple age-related disorders [119,120].”
BackgroundLugo, R., Gabasa, M., Andriani, F., Puig, M., Facchinetti, F., Ramírez, J., Gómez-Caro, A. A., Pastorino, U., Fuster, G., Almendros, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10327 · Cited by 24
“A major hallmark of senescent cells is that they exhibit an irreversible growth arrest, yet they remain viable and metabolically active [12, 13].”
BackgroundResultInfluentialZanellato, I., Bonarrigo, I., Ravera, M., Gabano, E., Gust, R., & Osella, D. (2013) · Metallomics · doi:10.1039/c3mt00117b · Cited by 25
Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues
Kochan, D. Z., Ilnytskyy, Y., Golubov, A., Deibel, S. H., McDonald, R. J., & Kovalchuk, O. (2015) · Oncoscience · doi:10.18632/oncoscience.157 · Cited by 25
“Because cell senescence plays an important role in tumour initiation, this dynamic warranted further investigation [42].”
BackgroundBientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 26
“Reverse primer IL-6 5 ’ -AGACAGCCACTCACCTCTTCAG-3 ′ 5 ’ -TTCTGCCAGTGCCTCTTTGCTG-3 ′ IL-8 5 ’ -GAGAGTGATTGAGAGTGGACCAC-3 ’ 5 ’ -CACAACCCTCTGCACCCAGTTT-3 ′ TGF β 1 5 ’ -TACCTGAACCCGTGTTGCTCTC-3 ′ 5 ’ -GTTGCTGAGGTATCGCCAGGAA-3 ′ IL-1 α 5 ’ -TGTATGTGACTGCCCAAGATGAAG-3 ′ 5 ’ -AGAGGAGGTTGGTCTCACTACC-3 ′ MMP2 5 ’ -AGCGAGTGGA…”
BackgroundInfluentialLiu, Y., Hawkins, O. E., Vilgelm, A. E., Pawlikowski, J. S., Ecsedy, J., Sosman, J. A., Kelley, M. C., & Richmond, A. J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0293 · Cited by 29
“Therefore, SASP includes both tumor-promoting and inhibitory cytokines and the effect of senescent cells in the tumor microenvironment is highly dependent on cell and tissue context (34).”
BackgroundImmune senescence and periodontitis: From mechanism to therapy
Liu, J., Dan, R., Zhou, X., Wang, J., Wang, J., & Liu, J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0822-645rr · Cited by 25
Rampal, R. K., Pinzon-Ortiz, M. C., Somasundara, A. V. H., Durham, B. H., Koche, R. P., Spitzer, B. G., Mowla, S., Krishnan, A., Li, B., An, W., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4898 · Cited by 30
Edler, M. K., Munger, E. L., Maycon, H., Hopkins, W. D., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25167 · Cited by 23
“…low- grade inflammation that triggers glial activation (Cotrina & Nedergaard, 2002; Dall'Olio et al., 2013; Finch, 2003; Franceschi, Bonafè, et al., 2000; Franceschi, Valensin, et al., 2000; Harman, 1956; Moller et al., 2010; Nichols et al., 1993; Poon et al., 2004; Rodier & Campisi, 2011).”
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Srdić‐Rajić, T., Santibanez, J. F., Kanjer, K., Miletić, N. T., Cavic, M. R., Galun, D., Jevric, M., Kardum, N., Konić‐Ristić, A., & Zoranovic, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03898-0 · Cited by 25
The Heart: Mostly Postmitotic or Mostly Premitotic? Myocyte Cell Cycle, Senescence, and Quiescence
Siddiqi, S., & Sussman, M. A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.014 · Cited by 27
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib
Porcelli, L., Mazzotta, A., Garofoli, M., Fonte, R., Guida, G., Guida, M., Tommasi, S., & Azzariti, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111006 · Cited by 24
Noh, H. J., Yang, H. H., Kim, G., Lee, S. E., Lee, D., Choi, J. H., Kim, S. Y., Lee, E. S., Ji, S. H., Kang, K. S., et al. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.995181 · Cited by 24
“Six compounds were isolated and identified as hericenone D (1), (22E,24R)-5a,8aepidioxyergosta-6,22-dien-3b-ol (2), erinacerin B (3), hericenone E (4), hericenone F (5) and isohericerin (6) by comparing their spectroscopic data with previously reported values.”
BackgroundMethodThe transcription factor code: a beacon for histone methyltransferase docking
Garcia, G. T., & Graf, T. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.04.001 · Cited by 30
Delay discounting, genetic sensitivity, and leukocyte telomere length
Yim, O. S., Zhang, X., Shalev, I., Monakhov, M. V., Zhong, S., Hsu, M., Chew, S. H., Lai, P. S., & Ebstein, R. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514351113 · Cited by 26
“Each division of a cell erodes telomere length, and when telomeres reach a critical short length, the cell enters senescence and no longer divides (6), although it may remain metabolically active and functioning.”
Unbalanced Growth, Senescence and Aging
Polymenis, M., & Kennedy, B. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57127-0_8 · Cited by 26
Reflections on the role of senescence during development and aging
Triana-Martínez, F., Pedraza-Vázquez, G., Maciel-Barón, L. Á., & Königsberg, M. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.04.004 · Cited by 24
Shining the Light on Senescence Associated LncRNAs
Ghanam, A. R., Xu, Q., Ke, S., Azhar, M., Cheng, Q., & Song, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0810 · Cited by 25
“Senescent cells with persistent DSBs activate DDR machinery network of proteins kinases such as ATM, ATR and DNA-PKCs, which in turn, attach to DNA segments and form persistent foci (DNA-SCRAS) [27] [11, 28], and are distinguishable from transient damage foci [29].”
Potukuchi, A., Addepally, U., Sindhu, K. K., & Raghunath, M. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1332509 · Cited by 23
Adult Neural Stem Cell Migration Is Impaired in a Mouse Model of Alzheimer’s Disease
Esteve, D., Molina‐Navarro, M. M., Giraldo, E., Martínez-Varea, N., Blanco-Gandia, M.-C., Rodríguez‐Arias, M., García‐Verdugo, J. M., Viña, J., & Lloret, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02620-6 · Cited by 25
Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Y-27632, a ROCK inhibitor, delays senescence of putative murine salivary gland stem cells in culture
Lee, J., Park, S., & Roh, S. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.03.003 · Cited by 24
Role of low-dose radiation in senescence and aging: A beneficial perspective
Xu, J., Liu, D., Zhao, D., Jiang, X. M., Meng, X., Jiang, L., Meina, Y., Zhang, L., & Jiang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120644 · Cited by 32
Badiola, I., Santaolalla, F., García-Gallastegui, P., del Rey, A. S., Unda, F. J., & Ibarretxe, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.004 · Cited by 24
Role of keratin 24 in human epidermal keratinocytes
Min, M., Chen, X., Wang, P., Landeck, L., Chen, J., Li, W., Cai, S., Zheng, M., & Man, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174626 · Cited by 23
Kim, K.-S., Thorp, H., Bou‐Ghannam, S., Grainger, D. W., & Okano, T. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3037 · Cited by 21
“FBS, fetal bovine serum; hPL, human platelet lysate [Colour figure can be viewed at wileyonlinelibrary.com] such as IL-1β and also upregulate β-galactosidase activity (Coppe, Desprez, Krtolica, & Campisi, 2010; Rodier & Campisi, 2011).”
BackgroundCostarelli, L., Giacconi, R., Malavolta, M., Basso, A., Piacenza, F., Provinciali, M., Maggio, M. G., Corsonello, A., & Lattanzio, F. (2016) · Biogerontology · doi:10.1007/s10522-016-9675-3 · Cited by 22
“Conversely, a persistent SASP production can cause local and systemic inflammation, disrupt tissue architecture, and stimulate growth of nearby malignant cells (Rodier and Campisi 2011).”
Kouroumalis, A., Mavrogonatou, E., Savvidou, O. D., Papagelopoulos, P. J., Pratsinis, H., & Kletsas, D. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.05.007 · Cited by 23
Porta, C. A. M. L., & Zapperi, S. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316271759 · Cited by 33
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells
Obajdin, J., Larcombe-Young, D., Glover, M., Kausar, F., Hull, C., Flaherty, K. R., Tan, G., Beatson, R., Dunbar, P. A., Mazza, R., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101827 · Cited by 29
“Notably p53 has also been implicated in cellular senescence 37 and is upregulated in CAR T cell products that have achieved poor results for patients.”
Guo, Y., Chomiak, A. A., Hong, Y., Lowe, C. C., Kopsidas, C. A., Chan, W., Andrade, J., Pan, H., Zhou, X., Monuki, E. S., et al. (2021) · iScience · doi:10.1016/j.isci.2022.104519 · Cited by 24
“A plausible mechanism for DNA damage to induce tissue-wide degeneration is via cellular senescence, a stress response that occurs when cells experience telomere erosion, chronic oncogenic stimulation, persistent DNA damage, oxidative and metabolic stresses, or mitochondrial dysfunction (Hayflick, 1965; Hernandez-Segur…”
BackgroundNoncanonical Roles of Lipids in Different Cellular Fates
Lizardo, D. Y., Parisi, L. R., Li, N., & Atilla‐Gokcumen, G. E. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00862 · Cited by 25
Song, W., Thakor, P., Vesey, D. A., Gobe, G. C., & Morais, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.126 · Cited by 22
Pan, W., Wang, Y., Bai, X., Yin, Y., Dai, L., Zhou, H., Wu, Q., & Wang, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00546-5 · Cited by 23
Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus
May, V. L. J. I., Berchtold, S., Berger, A., Venturelli, S., Burkard, M., Leischner, C., Malek, N. P., & Lauer, U. M. (2019) · Oncology Letters · doi:10.3892/ol.2019.10901 · Cited by 25
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
“SASP factors are secreted from senescent cells and contribute to chronic inflammation and senescence-related diseases (1, 38) .”
BackgroundRole of epigenetics in the regulation of skin aging and geroprotective intervention: A new sight
Pozzo, L. D., Xu, Z., Lin, S., Wang, J., Wang, Y., Enechojo, O. S., Abankwah, J. K., Peng, Y., Chu, X., Zhou, H., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116592 · Cited by 26
Voynova, E., Kulebyakin, K. Y., Grigorieva, O., Novoseletskaya, E. S., Basalova, N. A., Alexandrushkina, N., Arbatskiy, M. S., Vigovskiy, M. A., Sorokina, A., Zinoveva, A., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1050489 · Cited by 26
“Increasing evidence supports the hypothesis that cellular senescence recapitulates aspects of organism aging and contributes to aging phenotypes in vivo, in part by limiting self-renewal of tissues by stem and progenitor cells (Rando Thomas A. 2006; Sedivy JM et al., 2008; Rodier and Campisi 2011; Sikora et al., 2011;…”
BackgroundRoles of BCCIP deficiency in mammary tumorigenesis
Droz-Rosario, R., Lu, H., Liu, J., Liu, N.-A., Ganesan, S., Xia, B., Haffty, B. G., & Shen, Z. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0907-5 · Cited by 21
Wang, S., Wang, H., Sun, B., Li, D., Wu, J., Li, J., Tian, X., Qin, C., Chang, H., & Liu, Y. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12488 · Cited by 24
Samsonraj, R. M., Law, S. F., Chandra, A., & Pignolo, R. J. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101674 · Cited by 25
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
Krayem, M., Najem, A., Journé, F., Morandini, R., Salès, F., Awada, A. H., & Ghanem, G. (2018) · Oncotarget · doi:10.18632/oncotarget.25879 · Cited by 24
RetractedAnalysis of senescence in gingival tissues and gingival fibroblast cultures
Furukawa, M., Matsuda, K., Aoki, Y., Yamada, M., Wang, J., WATANABE, M., Kurosawa, M., Shikama, Y., & Matsushita, K. (2022) · Clinical and Experimental Dental Research · doi:10.1002/cre2.581 · Cited by 25
“It is known that the expression and secretion of inflammatory mediators are increased in senescent cells (Rodier & Campisi, 2011).”
BackgroundChacón, L. D. M. R., Yanes‐Diaz, J., de Lucas, B., Riestra‐Ayora, J., Madrid-García, R., Fernández, R. S., & Sánchez‐Rodríguez, C. (2023) · Nutrients · doi:10.3390/nu15030544 · Cited by 22
“In general, cells exhibited marked morphological changes characteristics of senescent cells, ranging from longer and thinner cells to ramified and enlarged cells and alterations in the organelles [42].”
Characterization of the EBV-Induced Persistent DNA Damage Response
Hafez, A. Y., & Luftig, M. A. (2017) · Viruses · doi:10.3390/v9120366 · Cited by 21
Cotarelo, C., Schad, A., Kirkpatrick, C. J., Sleeman, J. P., Springer, E., Schmidt, M., & Thaler, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12432 · Cited by 23
Dynamics of Senescent Cell Formation and Retention Revealed by p14ARF Induction in the Epidermis
Tokarsky-Amiel, R., Azazmeh, N., Helman, A., Stein, Y., Hassan, A., Maly, A., & Ben‐Porath, I. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3730 · Cited by 23
“Senescence is also detected during aging (16-18) and is thought to contribute to this process, potentially through the depletion of functional stem cells (1-3).”
BackgroundGermanio, C. D., Bernier, M., Petr, M. A., Mattioli, M., Barboni, B., & de Cabo, R. (2016) · Oncotarget · doi:10.18632/oncotarget.9694 · Cited by 21
“Despite some controversies [23], few studies have indicated that senescent cells have the ability to increase tumor cell proliferation through their inflammatory secretome [15].”
BackgroundHypoxia-induced senescence contributes to the regulation of microenvironment in melanomas
Mo, J., Sun, B., Zhao, X., Gu, Q., Dong, X., Liu, Z., Ma, Y., Zhao, N., Tang, R., Liu, Y., et al. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2013.07.004 · Cited by 23
DNA Damage and DNA Replication Stress in Yeast Models of Aging
Burhans, W. C., & Weinberger, M. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2561-4_9 · Cited by 24
Kim, S. G., Sung, J. Y., Kang, Y. J., & Choi, H. C. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.104927 · Cited by 24
Salas‐Silva, S., Nieves, A. S., López-Ramirez, J., Bucio, L., Gómez-Quiroz, L. E., Gutiérrez‐Ruíz, M. C., & Roma, M. G. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.044 · Cited by 22
Too big not to fail: emerging evidence for size‐induced senescence
Manohar, S., & Neurohr, G. E. (2023) · FEBS Journal · doi:10.1111/febs.16983 · Cited by 21
Early injury of the neonatal lung contributes to premature lung aging: a hypothesis
Meiners, S., & Hilgendorff, A. (2016) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0052-8 · Cited by 23
“Cellular senescence is a defined cellular program of aging that limits the replicative capacity of cells by cell cycle arrest, thereby preventing propagation of old and damaged cells [71].”
BackgroundThe role of autophagy in escaping therapy-induced polyploidy/senescence
Dudkowska, M., Staniak, K., Bojko, A., & Sikora, E. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.004 · Cited by 22
Iwao, T., Takata, F., Matsumoto, J., Goto, Y., Aridome, H., Yasunaga, M., Yokoya, M., Kataoka, Y., & Dohgu, S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.037 · Cited by 28
Arlia‐Ciommo, A., Svistkova, V., Mohtashami, S., & Titorenko, V. I. (2015) · Oncotarget · doi:10.18632/oncotarget.6440 · Cited by 23
hERG1 potassium channel in cancer cells: a tool to reprogram immortality
Gentile, S. (2016) · European Biophysics Journal · doi:10.1007/s00249-016-1169-3 · Cited by 19
Hodge, J., Decker, H. E., Robinson, J. L., & Mellott, A. J. (2023) · Wound Repair and Regeneration · doi:10.1111/wrr.13076 · Cited by 23
“Cellular senescence is a progressive, phenotypically diverse and multi-staged process of cellular aging and DNA damage, typically considered to result in irreversible cell cycle arrest.(57,58) The secretome of senescent cells, including MSCs, have been shown to negatively impact tissue regeneration and wound healing b…”
Ingenhag, D., Reister, S., Auer, F., Bhatia, S., Wildenhain, S., Picard, D. J., Remke, M., Hoell, J. I., Kloetgen, A., Sohn, D., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189407 · Cited by 22
“In general, gene expression, which triggers senescence, has the potential to initiate or promote carcinogenesis.(34) The induction of premature senescence following oncogene expression is known as oncogene-induced senescence.”
BackgroundRentscher, K. E., Carroll, J. E., Polsky, L. R., & Lamkin, D. M. (2022) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2022.100461 · Cited by 21
Yamada, T., KAMIYA, M., HIGUCHI, M., & NAKANISHI, N. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.18-0324 · Cited by 23
“Premature senescence leads to a senescence-associated secretory phenotype (SASP) characterized by the increased production of cytokines and matrix metalloproteinase (mmp) [40, 42, 50].”
BackgroundKim, H. J., Kim, B., Byun, H. J., Yu, L., Nguyen, T. M., Nguyen, T. H., Do, P. A., Kim, E. J., Cheong, K. A., Kim, K. S., et al. (2021) · Antioxidants · doi:10.3390/antiox10121924 · Cited by 28
let‐7‐repressesed S hc translation delays replicative senescence
Xu, F., Pang, L., Cai, X. T., Liu, X., Yuan, S., Fan, X., Jiang, B., Zhang, X., Dou, Y., Gorospe, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12176 · Cited by 21
Leong, P. K., Chen, N., & Ko, K. M. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05600.x · Cited by 21
“Furthermore, the NF-jB-induced expression of a range of inflammatory cytokines has been postulated to promote the senescent phenotype in cells.(83) In this connection, the suppression of the ageinginduced activation of the NF-jB system may retard the ageing process.”
BackgroundActivatable Fluorescent Probe for Studying Drug-Induced Senescence In Vitro and In Vivo
Li, Z., Huang, P. C., Wu, G., & Lin, W. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02423 · Cited by 22
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
Troise, D. E., Infante, B., Mercuri, S., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Pontrelli, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082163 · Cited by 22
Turan, B. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1464-1 · Cited by 20
Kadamb, R., Leibovitch, B. A., Farias, E., Dahiya, N. R., Suryawanshi, H., Bansal, N., & Waxman, S. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101320 · Cited by 20
“Senescence can serve as a barrier against cancer progression or may promote tumorigenesis in a context dependent manner [59].”
BackgroundMikyšková, R., Sapeg, O., Psotka, M., Novotny, O., Hodný, Z., Balintova, S., Maliňák, D., Svobodová, J., Andrýs, R., Rysanek, D., et al. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12968 · Cited by 21
Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program
Helbling-Leclerc, A., Dessarps-Freichey, F., Evrard, C., & Rosselli, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-53502-w · Cited by 22
Husari, A., Steinberg, T., Dieterle, M. P., Prucker, O., Rühe, J., Jung, B. A., & Tomakidi, P. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109382 · Cited by 21
Napolitano, M. A., Comegna, M., Succoio, M., Leggiero, E., Pastore, L., Faraonio, R., Cimino, F., & Passaro, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098669 · Cited by 21
“Nevertheless, despite their inability to replicate, senescent cells are metabolically active and develop an aberrant gene expression profile with proinflammatory behaviour, the so-called Senescence Associated Secretory Phenotype (SASP), that can induce or accelerate changes in normal surrounding tissues, explaining th…”
BackgroundMethodInfluentialEffects of senescent secretory phenotype acquisition on human retinal pigment epithelial stem cells
Lazzarini, R., Nicolai, M., Pirani, V., Mariotti, C., & Primio, R. D. (2018) · Aging · doi:10.18632/aging.101624 · Cited by 20
“Cellular senescence is characterized by cell growth arrest, altered DNA synthesis and repair, resistance to apoptosis, and increased cell size [21].”
BackgroundCarey, J. P. W., Knowell, A. E., Chinaranagari, S., & Chaudhary, J. (2013) · PubMed · Cited by 20
Morsczeck, C. O., Gresser, J., & Ettl, T. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2708-z · Cited by 21
Chen, B., Liang, Y., Chen, L., Wei, Y., Li, Y., Zhao, W., & Wu, J. (2018) · Journal of Cancer · doi:10.7150/jca.23967 · Cited by 22
“First, SASP factors support tumor cell invasion and metastasis by disrupting and remodeling tissue structure [7, 17].”
BackgroundZhang, H., Lei, Z., Tian, R., et al. (2017) · Talanta · doi:10.1016/j.talanta.2017.09.034 · Cited by 20
Ji, W., Zhou, H., Liang, W., Zhang, W., Gong, B., Yin, T., Chu, J., Zhuang, J., Zhang, J., Luo, Y., et al. (2024) · Small · doi:10.1002/smll.202308574 · Cited by 29
Sticky-flares for in situ monitoring of human telomerase RNA in living cells
Wu, Q., Liu, Z., Su, L., Han, G., Liu, R., Zhao, J., Zhao, T., Jiang, C., & Zhang, Z. (2018) · Nanoscale · doi:10.1039/c8nr01260a · Cited by 20
Vidale, P., Magnani, E., Nergadze, S. G., Santagostino, M., Cristofari, G., Smirnova, A., Mondello, C., & Giulotto, E. (2012) · Chromosoma · doi:10.1007/s00412-012-0379-4 · Cited by 19
“Thus, telomeres progressively shorten until they reach a critical length that induces an irreversible growth arrest known as replicative senescence (Rodier and Campisi 2011).”
BackgroundA Link between Replicative Stress, Lamin Proteins, and Inflammation
Willaume, S., Rass, E., Fontanilla-Ramirez, P., Moussa, A., Wanschoor, P., & Bertrand, P. (2021) · Genes · doi:10.3390/genes12040552 · Cited by 29
Luca, F. D., Camporeale, V., Leccese, G., Cuttano, R., Troise, D. E., Infante, B., Stallone, G., Netti, G. S., & Ranieri, E. (2025) · Cells · doi:10.3390/cells14221831 · Cited by 28
“For example, SASP may attract innate and adaptive immune cells near tumor cells [29] and a persistent secretion may cause chronic systemic inflammation and tissue damage and inhibit immune cell function in the elderly [30].”
Cellular Senescence: A Bridge Between Diabetes and Microangiopathy
Liu, J., Guo, B., Liu, Q., Zhu, G., Wang, Y., Wang, N., Yang, Y., & Fu, S. (2024) · Biomolecules · doi:10.3390/biom14111361 · Cited by 23
“It is manifested by large and flat senescent cells [21], a significantly shortened telomere length [22], abnormal heterochromatin concentration [23], increased activity of negative regulators in cells such as p53/p21CIP1 and p16INK4a/pRb [24–26], the activation of β -galactosidase [27], and the…”
Sekhri, K. (2014) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.138797 · Cited by 20
Repurposing digoxin for geroprotection in patients with frailty and multimorbidity
Lee, H., Wilson, D. V., Bunting, K. V., Kotecha, D., & Jackson, T. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101860 · Cited by 20
“Senescent cells accumulate cyclin-dependent kinase inhibitors p21WAF1/Cip1 (CDKN1A) and p16INK4A (CDKN2A), preventing the phosphorylation of pRB required for cell-cycle progression (Rodier and Campisi, 2011; Sharpless and Sherr, 2015).”
BackgroundHyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines
Lompardía, S., Díaz, M., Pibuel, M., Papademetrio, D., Poodts, D., Mihalez, C., Álvarez, É., & Hajos, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-47248-8 · Cited by 19
Late Passage Cultivation Induces Aged Astrocyte Phenotypes in Rat Primary Cultured Cells
Bang, M., Gonzales, E. L., Shin, C. Y., & Kwon, K. J. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.175 · Cited by 19
“Excessive SASP activity was suppressed by reducing the inflammatory cytokine levels (Bhaumik et al., 2009; Rodier and Campisi, 2011).”
BackgroundHam, H.-J., Park, J., & Bae, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.4.156 · Cited by 19
“Cellular senescence is the state of irreversible cell cycle arrest at the G1 phase (1-4).”
BackgroundOishi, H., Doi, S., Nakashima, A., Ike, T., Maeoka, Y., Sasaki, K., Doi, T., & Masaki, T. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00609.2020 · Cited by 26
Bikkul, M. U., Faragher, R., Worthington, G. L., Meinke, P., Kerr, A. R. W., Aakila, S., Riyahi, K., Horton, D., Schirmer, E. C., Hubank, M. J. F., et al. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22711 · Cited by 25
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
Hafez, H. M., Abdel‐Hakeem, E. A., & Hassanein, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01856-8 · Cited by 19
Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
Smigiel, J. M., Taylor, S. E., Bryson, B. L., Tamagno, I., Polak, K. L., & Jackson, M. W. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.26 · Cited by 20
“However, paracrine signaling by SASP components can also influence the behavior of adjacent cells, engaging signaling programs that contribute to tumor progression and therapy failure([64,84-89]).”
BackgroundPan, C. C., Maeso‐Díaz, R., Lewis, T. R., Xiang, K., Tan, L., Liang, Y., Wang, L., Yang, F., Yin, T., Wang, C., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00820-4 · Cited by 20
“Senescent cells share several common features, such as a flattened morphology, p16 and/or p53/p21 induction, β-galactosidase expression, apoptosis resistance, and the expression of a pro-inflammatory senescenceassociated secretory phenotype (SASP).(3) Owing to its induction in response to DNA damage and oncogenic stre…”
BackgroundSenescence of Alveolar Stem Cells Drives Progressive Pulmonary FibrosisPreprint
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G., Soukiasian, H. J., David, G., WEIGT, S. S., Belperio, J. A., et al. (2019) · SSRN Electronic Journal · doi:10.1101/820175 · Cited by 21
“These changes in the molecular phenotype of AT2 cells were accompanied by dramatic increases in the size of AT2 cells (Fig 2D-F and Supplemental Figure 4A), a characteristic feature of senescent cells (54, 55), Indeed, at 6 weeks post-tamoxifen treatment, the average cross-sectional surface area of AT2 cells increased…”
BackgroundKokubun, T., Saitoh, S., Miura, S., Ishida, T., & Takeishi, Y. (2019) · International Heart Journal · doi:10.1536/ihj.18-564 · Cited by 19
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.